1. India Stocks

  2. •

    Basic Materials

  3. •

    Chemicals
Paushak Limited

Paushak Limited

PAUSHAKLTD.BO
Paushak LimitedIN flagBombay Stock Exchange
566.70
INR
+20.35
- -
1.75BMarket Cap
Paushak Limited
PAUSHAKLTD.BO
(Bombay Stock Exchange)

Recent

price

566.70

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
11.61
13.09
19.8
21.95
26.89
30.36
25.66
39.59
55.27
55.24
56.59
60.23
85.48
83.08
84.98
88.04
113.43
Revenue per Share
1.44
1.34
3.04
3.44
5.06
4.84
4.26
8.37
15.71
14.16
15.13
15.25
21.9
22.04
20.03
15.95
20.4
Basic EPS, GAAP
0.14
-0.26
0.69
2.09
0.1
-1.18
2.68
1.89
5.31
9.83
-10.53
-1.73
10.37
6.87
-49.83
-13.97
- -
Free Cash Flow per Basic Share
0.23
0.23
0.23
0.35
0.35
0.35
0.37
0.37
0.37
0.62
0.75
0.75
1.49
2.16
2.45
2.45
- -
Dividend per Share
4.86
5.52
6.17
6.25
6.92
7.41
11.65
15.65
31.43
40.88
51.16
61.64
82.08
101.88
119.34
136.54
174.7
Book Value per Share
11.15
12.2
14.8
17.8
22.37
28.96
32.36
44.09
71.57
92.13
110.1
123.87
143.41
165.5
188.77
199.16
254.81
Tangible Book Value per Share
26
26
26
26
26
26
26
26
25
25
25
25
25
25
25
25
19
Basic Weighted Avg Shares
298
336
508
563
690
779
658
1,016
1,371
1,362
1,395
1,485
2,108
2,048
2,095
2,171
2,186
Sales/Revenue/Turnover
14.56
9.94
19.23
19.75
24.63
19.26
13.95
25.95
26.6
28.23
32.66
30.54
29.35
25.2
21.71
18.44
18.03
Operating Margin (%)
16
17
18
18
21
28
32
34
39
44
50
90
134
138
150
214
214
Depreciation Expense
37
34
78
88
130
124
109
215
390
349
373
376
540
544
494
393
393
Net Income, GAAP
23.41
16.52
27.37
30.1
27.76
25.24
22.49
25.62
20.48
23.06
27.7
25.19
25.22
23.44
15.99
21.99
22.02
Effective Tax Rate (%)
12.42
10.26
15.34
15.66
18.84
15.94
16.62
21.14
28.41
25.63
26.73
25.32
25.62
26.53
23.57
18.11
17.99
Profit Margin (%)
51
73
163
249
289
299
191
334
751
943
677
765
1,249
1,896
551
662
662
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
250
600
600
LT Debt
286
313
380
457
574
743
830
1,131
1,776
2,272
2,717
3,056
3,537
4,081
4,655
4,911
4,911
Total Equity
11.35
8.58
19.37
18.33
23.66
16.81
8.94
19.56
19.54
14.5
13.18
11.71
13.96
10.31
8.42
5.85
5.76
Return on Invested Capital (%)
29.45
21.76
45.83
53.72
76.38
66.22
44.31
60.78
65.65
39.06
32.87
27.05
30.58
24.01
17.34
10.96
10.97
Return on Capital (%)
32.22
25.89
51.97
55.37
76.94
67.56
44.76
61.31
65.96
39.06
32.87
27.05
30.48
23.97
18.11
12.47
12.46
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
60
- -
169
LT Borrowings
540
- -
600
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
25
- -
25
Market Capitalization
17,031
11,430
6,661

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
1,044
- -
1,317
Cash, Cash Equivalents & STI
98
- -
274
Accounts Receivable, Net
565
- -
549
Inventories
230
- -
366
Total Current Liabilities
436
- -
654
Payables & Accruals
- -
- -
- -
ST Debt
60
- -
169
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
21.57%
12.64%
5.51%
Free Cash Flow
-202.08%
-342.7%
-71.97%
Net Income, GAAP
17.78%
3.11%
-20.36%
Sales/Revenue/Turnover
12.7%
10.29%
3.61%
Total Cash Common Dividend
24.55%
31.46%
-0.02%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
486
520
518
524
2,048
2025
520
573
493
524
2,095
2026
559
588
488
551
2,171

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
29.65
43.25
44.22
- -
22.04
2025
33.45
46.07
6.19
3.9
20.03
2026
39.03
3.49
2.5
5.07
15.95

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
2.16
2025
- -
- -
- -
- -
2.45
2026
- -
- -
- -
- -
2.45
Similar Companies
AdvanSix Inc. (ASIX)
Indorama Ventures Public Company Limited (IVL-R.BK)
Zhejiang Guanghua Technology Co., Ltd. (001333.SZ)
China Chemical Corp. (CHCC)
ISU Specialty Chemical Co., Ltd. (457190.KS)
Zhejiang Runyang New Material Technology Co., Ltd. (300920.SZ)
Business
Paushak Limited is a specialty chemicals company primarily engaged in the production of phosgene gas and phosgene-based specialty chemicals and intermediates, including isocyanates, chloroformates, and chlorides. It also offers contract development and manufacturing organization (CDMO) services, advanced research and development capabilities for proprietary molecules, and engineering and design services. The company serves pharmaceutical, agrochemical, and other industrial sectors with multipurpose plants capable of handling complex manufacturing requirements at various scales. It operates globally with a strong focus on safe, sustainable, and reliable phosgene chemistry and supply security. Founded in 1968 and headquartered in India, Paushak is recognized as the largest phosgene-based specialty chemical producer in India. Recent major developments include a strategic expansion approved by Indian authorities to triple its phosgene production capacity from 4,800 metric tons to 14,400 metric tons, funded through internal accruals, aimed at achieving economies of scale and enhancing cost competitiveness globally. Paushak has launched innovative products such as the patented, CIB-approved agricultural yield enhancer "Paushak Super Star," developed with advanced research collaborations to improve crop growth and soil health. The company has also announced a stock split and bonus issue in 2025 to enhance liquidity. Paushak continues to pursue import substitution by developing indigenous technology for key specialty chemicals, reinforcing its position in the domestic and international markets. It is part of a group structure involving Alembic Limited and related entities, focusing on vertical integration and simplification of operations.